Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRospective Multiple Myeloma Impact Study

NCT: NCT02911571 · ACTIVE_NOT_RECRUITING

NCT IDNCT02911571

StatusACTIVE_NOT_RECRUITING

Start Date2018-02-27

Completion2026-10-01

Brief Summary

This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑